trial

The Effect of Salutogenic-based Interviewing on Subjective Recovery and Quality of Life in Schizophrenia

NCTId NCT06820580
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Not Yet Recruiting
Enrollment 60 (estimated)
Sponsored by Ataturk University
Primary completion 2025-10-26
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Not Yet Recruiting
Enrollment
60 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2025-02-20
Primary completion
2025-10-26
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
Salutogenic Approach Based Interview

Sponsors

Ataturk UniversityLead Sponsor

Investigators

2
Şeyda Erçel, MScPrincipal Investigator
Sibel Asi KarakaşPrincipal Investigator

Sites

1 total
Elâzığ, Turkey (Türkiye)

Facts & assertions

4 sourced
Enrollment
60
Phase
NA
Primary Completion Date
2025-10-26
Status
NOT_YET_RECRUITING
relationships
The graph out of here
drug
Salutogenic Approach Based Interview
drug
lead_sponsor
Ataturk University
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Şeyda Erçel, MSc
person
Sibel Asi Karakaş
person